镇静催眠药市场面面观  

View on the insomnia market

作　　者：华平[1] 王美红[2] 沈承武[3] 石永进[4] 

机构地区：[1]山东大学医院与卫生管理处,济南250100 [2]山东大学校医院,济南250100 [3]山东省立医院,济南250021 [4]上海医药工业研究院,上海200040

出　　处：《世界临床药物》2009年第6期377-380,共4页World Clinical Drug

摘　　要：受品牌药专利到期的影响,全球镇静催眠药市场在未来几年内的年均复合增长率将下降至-9.3%。而国内镇静催眠市场趋势与国外不同,随着临床用药结构的进一步优化,未来几年的年均复合增长率预计都将保持在2位数以上。The insomnia market is forecast to be adversely affected by patent expiries and the compound annual growth rate （CAGR） of which is predicted to decline at -9.3% in the coming years. Conversely, with the improvement of the clinical drugs the CAGR of Chinese insomnia market is predicted to increase at double-digit rates in the coming years.

关 键 词：失眠症 市场 年均复合增长率 

分 类 号：F416.7[经济管理—产业经济]